Cambridge Innovation Capital

Portfolio Companies 2026 for Cambridge Innovation Capital: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Cambridge Innovation Capital accounts for 13 tracked companies with verified cap-table data, 13 of which disclose round sizes totalling $1.1B. The median disclosed raise is $79M, and the largest is UpStream Care at $185M, ahead of Gyroscope Therapeutics ($148M) and Nuclera ($145M).

The names that recur most often on these portfolio cap tables are Cambridge Innovation Capital (13 companies), British Patient Capital (3 companies), Amadeus Capital Partners (3 companies), Tencent (3 companies), ARCH Venture Partners (2 companies), Jonathan Milner (2 companies). By latest disclosed round, the market skews Series B (5), Series C (4), Series A (2).

Best funded Cambridge Innovation Capital companies

  1. UpStream Care — $185M (latest: Series B)
  2. Gyroscope Therapeutics — $148M (latest: Series C)
  3. Nuclera — $145M (latest: Series C)
  4. T-Therapeutics — $91M (latest: Series A)
  5. Immutrin — $87M (latest: Series A)
  6. Congenica — $82M (latest: Series C)
  7. Sense Biodetection — $79M (latest: Series B)
  8. Microbiotica — $73M (latest: Series B)
  9. Carrick Therapeutics — $60M (latest: Series C)
  10. Epitopea — $45M
  11. Riverlane — $40M
  12. PetMedix — $37M (latest: Series B)
  13. Cambridge GaN Devices — $29M (latest: Series B)

Cambridge Innovation Capital — related firms and companies (56)

Cambridge Innovation Capital alternatives · All research reports